Prognostic Values for the mRNA Expression of the ADAMTS Family of Genes in Gastric Cancer

Table 3

Correlation between genes expression of ADAMTS family and OS in gastric cancer patients of different genders.

ADAMTSs gene chip	Gender female (n = 244); male (n = 567)	HR (95% CI)	value	ADAMTSs RNA-seq	Gender female (n = 133); male (n = 238)	HR (95% CI)	value
ADAMTS1	Female	1.63 (1.05–2.50)	0.03	ADAMTS1	Female	1.37 (0.76–2.47)	0.29
	Male	1.63 (1.21–2.20)	<0.01		Male	1.39 (0.94–2.06)	0.10
ADAMTS2	Female	1.27 (0.83–1.95)	0.27	ADAMTS2	Female	1.59 (0.87–2.89)	0.13
	Male	1.68 (1.24–2.26)	<0.01		Male	1.16 (0.79–1.72)	0.45
ADAMTS3	Female	1.56 (1.09–2.22)	0.01	ADAMTS3	Female	1.27 (0.86–1.88)	0.23
	Male	1.24 (1.00–1.53)	0.05		Male	1.65 (0.90–3.02)	0.10
ADAMTS4; (Not find)	—			ADAMTS4	Female	0.86(0.48–1.54)	0.60
					Male	1.62(1.09–2.43)	0.02
ADAMTS5	Female	1.75 (1.13–2.70)	0.01	ADAMTS5	Female	1.65 (0.91–2.98)	0.10
	Male	1.47 (1.09–1.98)	0.01		Male	1.01 (0.68–1.49)	0.97
ADAMTS6	Female	1.57 (1.02–2.42)	0.04	ADAMTS6	Female	2.36 (1.28–4.35)	<0.01
	Male	1.76 (1.31–2.38)	<0.01		Male	1.47 (0.99–2.18)	0.05
ADAMTS7	Female	1.64 (1.07–2.52)	0.02	ADAMTS7	Female	1.35 (0.74–2.45)	0.32
	Male	1.88 (1.40–2.53)	<0.01		Male	1.48 (0.99–2.21)	0.05
ADAMTS8	Female	1.98 (1.28–3.08)	<0.01	ADAMTS8	Female	1.04 (0.58–1.86)	0.91
	Male	1.31 (0.97–1.76)	0.07		Male	1.16 (0.79–1.72)	0.45
ADAMTS9	Female	1.58 (1.03–2.43)	0.03	ADAMTS9	Female	1.72 (0.94–3.14)	0.08
	Male	1.27 (0.95–1.70)	0.11		Male	1.43 (0.97–2.13)	0.07
ADAMTS10	Female	1.08 (0.70–1.65)	0.73	ADAMTS10	Female	1.66 (0.91–3.01)	0.09
	Male	0.94 (0.70–1.26)	0.67		Male	1.26 (0.85–1.86)	0.25
ADAMTS12	Female	1.67 (1.17–2.37)	<0.01	ADAMTS12	Female	2.02 (1.10–3.70)	0.02
	Male	1.30 (1.05–1.61)	0.02		Male	1.63 (1.00–2.66)	<0.05
ADAMTS13	Female	0.94 (0.62–1.45)	0.79	ADAMTS13	Female	0.63 (0.35–1.15)	0.13
	Male	1.15 (0.86–1.54)	0.34		Male	0.87 (0.59–1.29)	0.49
ADAMTS14	Female	1.23 (0.80–1.89)	0.35	ADAMTS14	Female	1.09 (0.61–1.97)	0.76
	Male	1.80 (1.33–2.43)	<0.01		Male	1.00 (0.67–1.47)	0.98
ADAMTS15	Female	1.22 (0.79–1.87)	0.37	ADAMTS15	Female	0.86 (0.48–1.55)	0.61
	Male	1.23 (0.92–1.65)	0.16		Male	1.87 (1.25–2.79)	<0.01
ADAMTS16	Female	1.34 (0.87–2.05)	0.18	ADAMTS16	Female	1.83 (1.01–3.32)	0.04
	Male	1.08 (0.80–1.45)	0.61		Male	1.87 (1.25–2.79)	<0.01
ADAMTS17	Female	1.31 (0.85–2.01)	0.22	ADAMTS17	Female	0.78 (0.43–1.41)	0.41
	Male	1.12 (0.83–1.50)	0.45		Male	0.87 (0.59–1.29)	0.49
ADAMTS18	Female	1.32 (0.86–2.02)	0.21	ADAMTS18	Female	2.25 (1.23–4.10)	<0.01
	Male	1.43 (1.06–1.92)	0.02		Male	1.36 (0.92–2.02)	0.13
ADAMTS19	Female	1.22 (0.79–1.87)	0.36	ADAMTS19	Female	0.89 (0.49–1.60)	0.70
	Male	0.96 (0.72–1.30)	0.81		Male	1.26 (0.85–1.86)	0.25
ADAMTS20	Female	1.98 (1.38–2.83)	<0.01	ADAMTS20	Female	1.14 (0.64–2.06)	0.65
	Male	1.67 (1.35–2.07)	<0.01		Male	1.12 (0.75–1.65)	0.58